Carol Bogdan
Hematology & Oncology · Georgetown, SCNPI 1033102538
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,148 of the $2,803 with a category attached, or 76.6%. 32 manufacturers reported payments, led by Novartis at 25.9% of the total. Reporting peaked in 2019 at $778 and has fallen 98.1% since, to $15 in 2024. That places this record below the midpoint for hematology & oncology clinicians in SC, where the typical reported total is $4,020.
Across 143 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$727
- Johnson & Johnson$199
- Amgen$178
- Merck$161
- E.r. Squibb & Sons, L.L.C.$133
- Bristol Myers Squibb$128
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,14877%
- Education$1124%
- Gifts$54319%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 28 | $727 |
| Johnson & Johnson | 7 | $199 |
| Amgen | 10 | $178 |
| Merck | 10 | $161 |
| E.r. Squibb & Sons, L.L.C. | 8 | $133 |
| Bristol Myers Squibb | 7 | $128 |
| Pfizer | 8 | $120 |
| Genentech USA, Inc. | 8 | $118 |
| AstraZeneca(2 entities) | 6 | $107 |
| Incyte Corporation | 5 | $106 |
| Daiichi Sankyo Inc. | 5 | $93 |
| Gilead(2 entities) | 5 | $93 |
| Lilly USA, LLC | 4 | $77 |
| Eisai Inc. | 4 | $77 |
| GSK | 3 | $69 |
| Astellas Pharma US Inc | 3 | $62 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| Rigel Pharmaceuticals, Inc. | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Seagen Inc. | 2 | $30 |
| Coherus Oncology, Inc. | 2 | $29 |
| Morphosys, US Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $19 |
| Sanofi | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $16 |
| Array Biopharma Inc | 1 | $15 |
| Mirati Therapeutics, Inc. | 1 | $14 |
| Karyopharm Therapeutics Inc. | 1 | $12 |
| Bayer | 1 | $12 |
How this compares
$2,803 in reported general payments places this provider in the 40th percentile of 166 hematology & oncology providers in South Carolina.
Other hematology & oncology in Georgetown
- Suzanne FanningGreenville$927K
- Vikas DemblaSpartanburg$568K
- Stephen DyarGreenville$413K
- Kashyap PatelRock Hill$379K
- Tondre BuckSpartanburg$366K
- Bhumika PatelGreenville$225K
- Ming LimCharleston$94K
- George GeilsCharleston$76K
- Joe StephensonGreenville$57K
- Sashi NaiduRock Hill$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.